DrugPatentWatch Database Preview
Drugs in Development Information for Tosedostat
» See Plans and Pricing
What is the development status for investigational drug Tosedostat?
Tosedostat is an investigational drug.
There have been 11 clinical trials for Tosedostat.
The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2012.
The most common disease conditions in clinical trials are Leukemia, Myeloid, Acute, Leukemia, Myeloid, and Leukemia. The leading clinical trial sponsors are Chroma Therapeutics, CTI BioPharma, and Fred Hutchinson Cancer Research Center.
There is one US patent protecting this investigational drug and seven international patents.
Summary for Tosedostat
| US Patents | 1 |
| International Patents | 7 |
| US Patent Applications | 2 |
| WIPO Patent Applications | 165 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2012-05-01) |
| Vendors | 43 |
Recent Clinical Trials for Tosedostat
| Title | Sponsor | Phase |
|---|---|---|
| Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma | Washington University School of Medicine | Phase 1/Phase 2 |
| Study of Clinical Efficacy and Safety of Tosedostat in MDS | CTI BioPharma | Phase 2 |
| Study of Clinical Efficacy and Safety of Tosedostat in MDS | Weill Medical College of Cornell University | Phase 2 |
Clinical Trial Summary for Tosedostat
Top disease conditions for Tosedostat
Top clinical trial sponsors for Tosedostat
US Patents for Tosedostat
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Tosedostat | Start Trial | Antibacterial hydroxamic acid derivatives | British Biotech Pharmaceuticals, Ltd. (Oxford, GB) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Tosedostat
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Tosedostat | Austria | AT299701 | 2019-01-29 | Start Trial |
| Tosedostat | Australia | AU2118900 | 2019-01-29 | Start Trial |
| Tosedostat | Germany | DE60021347 | 2019-01-29 | Start Trial |
| Tosedostat | European Patent Office | EP1146867 | 2019-01-29 | Start Trial |
| Tosedostat | United Kingdom | GB9901863 | 2019-01-29 | Start Trial |
| Tosedostat | Japan | JP2002535362 | 2019-01-29 | Start Trial |
| Tosedostat | World Intellectual Property Organization (WIPO) | WO0044373 | 2019-01-29 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
